The Impact of the Addition of Pertuzumab to Neoadjuvant HER2 Targeting on Pathological Complete Response (pCR) Rates: Kent Oncology Centre (KOC) Experience. Issue 7 (July 2019)

Record Type:
Journal Article
Title:
The Impact of the Addition of Pertuzumab to Neoadjuvant HER2 Targeting on Pathological Complete Response (pCR) Rates: Kent Oncology Centre (KOC) Experience. Issue 7 (July 2019)
Main Title:
The Impact of the Addition of Pertuzumab to Neoadjuvant HER2 Targeting on Pathological Complete Response (pCR) Rates: Kent Oncology Centre (KOC) Experience
Authors:
Sim, V.
Forner, S.
Burcombe, R.
Glendenning, J.
Abstract:
Is Part Of:
Clinical oncology. Volume 31:Issue 7(2019)
Journal:
Clinical oncology
Issue:
Volume 31:Issue 7(2019)
Issue Display:
Volume 31, Issue 7 (2019)
Year:
2019
Volume:
31
Issue:
7
Issue Sort Value:
2019-0031-0007-0000
Page Start:
e114
Page End:
Publication Date:
2019-07
Subjects:
Oncology -- Periodicals
Tumors -- Periodicals
Cancer -- Treatment -- Periodicals
Radiotherapy -- Periodicals
Neoplasms -- Periodicals
Cancer -- Radiotherapy
Cancer -- Treatment
Oncology
Medical radiology
Radiotherapy
Tumors
Electronic journals
Periodicals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09366555 ↗
http://www.elsevier.com/journal ↗
DOI:
10.1016/j.clon.2019.03.034 ↗
Languages:
English
ISSNs:
0936-6555
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3286.317000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
25546.xml